Clinical Trials in San Diego

Showing 1761-1780 of 14,679 trials

Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder

NCT06233799

The primary objective of this study is to evaluate the efficacy of extended release naltrexone plus bupropion XL (XR-NTX/BUP-XL) compared to matched injectable and oral placebo (iPLB/oPLB) in reducing methamphetamine (MA) use in individuals with moderate or severe methamphetamine use disorder (MUD) seeking to stop or reduce MA use.

Methamphetamine-dependenceMethamphetamine Abuse

National Institute on Drug Abuse (NIDA)360 participantsStarted Jul 2024

Little Rock, Arkansas, United States • Los Angeles, California, United States • San Diego, California, United States +8 more locations

RECRUITING< 1 mile

A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated With Percutaneous Ablation and Palliative Radiation Therapy

NCT06859801

The objective of this study is to evaluate real-world outcomes (e.g., pain, patient reported outcomes, skeletal related events, healthcare utilization, etc.) in patients treated with both percutaneous ablation and palliative radiation therapy (RT).

Bone Cancer Metastatic

Society of Interventional Oncology120 participantsStarted Oct 2025

San Diego, California, United States • Atlanta, Georgia, United States • Atlanta, Georgia, United States +3 more locations

Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder

A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated With Percutaneous Ablation and Palliative Radiation Therapy

Find Trials by Condition in San Diego

DAY101 In Gliomas and Other Tumors

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis

Non-Invasive Detection of Right-to-Left Cardiac Shunts

Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis

A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

Efficacy and Safety Study of Benralizumab in Patient With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps (ORCHID)

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

A Study of Pembrolizumab/Vibostolimab (MK-7684A) in Relapsed/Refractory Hematological Malignancies (MK-7684A-004, KEYVIBE-004)

Phase I Study of APX005M in Pediatric Central Nervous System Tumors

Myriad™ Augmented Soft Tissue Reconstruction Registry

Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003, KEYVIBE-003)

A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies